Microarray assays can measure the transcriptional effects of changes in gene function under different conditions. They can reveal genes that characterize tissue type, developmental stage ...

1 But, microarray technology isn't as flawed as it was feared to ... Explore how the design and application of appropriate assay controls ensure accurate and reproducible qPCR results. Takara Bio USA ...

Tissue microarrays (TMAs) have become ubiquitous ... Optimization of immunohistochemistry assays has typically been a subjective, manual process, which can be improved using objective and ...

AliveDx’s CE mark for the systematic autoimmune rheumatic disease (SARD) assay marks its fifth approval in the past 18 months ...

Most genotyping assays employ polymerase chain reaction (PCR) to make the genome's 3 billion base complexity manageable. But ideally these assays would mirror gene expression and employ a single-tube ...

InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.

The MammaPrint™ assay (Agendia BV, The Netherlands) is the first fully commercialized microarray-based multigene assay designed to individualize treatment for patients with breast cancer.

For Celiac Disease, the multiplex assay is designed to rapidly detect and identify up to 425 disease markers per hour. Seamless, microarray-internal calibration and quality control as well as ...

AliveDx seeks US FDA 510(k) premarket approval for MosaiQ AiPlex CD multiplex microarray: Eysins, Switzerland Tuesday, February 11, 2025, 12:00 Hrs [IST] AliveDx, an established c ...

The MosaiQ AiPlex CD is designed to improve the  accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows EYSINS, Switzerland , Feb.